A monoclonal antibody specific for a unique biomarker, virenose, in a lipopolysaccharide of Coxiella burnetii K. Palkovicova, R. Ihnatko, P. Vadovic,

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents

Vaccines for the elderly

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

M. Benoit, Y. Bechah, C. Capo, P.J. Murray, J.L. Mege, B. Desnues

R. Cavallo Clinical Microbiology and Infection

Immunosuppressive monoclonal antibodies: current and next generation

H. Lepidi, F. Gouriet, D. Raoult Clinical Microbiology and Infection

Gut bacterial microbiota and obesity

Approach to diagnosis of infective endocarditis

S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler

Herpes zoster in non-hospitalized children

Migrant health—a cause for concern?

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

J.-P. Van geertruyden Clinical Microbiology and Infection

R. Cantón Clinical Microbiology and Infection

P. Nordmann, L. Poirel Clinical Microbiology and Infection

Louis Pasteur, from crystals of life to vaccination

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Intracellular trafficking of the Coxiella burnetii lipopolysaccharide

Prevalence of Toscana virus antibodies in residents of Croatia

Surveillance of Legionnaires’ disease in Austria

How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach D. Guillemot Clinical Microbiology.

Results from a mathematical model for human monocytic ehrlichiosis

B. Desnues, G. Imbert, D. Raoult, J.-L. Mege, E. Ghigo

Vector control: a cornerstone in the malaria elimination campaign

New Delhi metallo-beta-lactamase (NDM-1): towards a new pandemia?

Training for the infectious diseases speciality in Norway

Rickettsia prowazekii infection of endothelial cells increases leukocyte adhesion through αvβ3 integrin engagement Y. Bechah, C. Capo, G. Grau, D. Raoult,

Estimation of delay in detecting hepatitis C virus antibodies in pools compared to individual testing on seroconversion panels B. Sarov, L. Novack, N.

R. Karakus, K. Caglar, C. Aybay Clinical Microbiology and Infection

Laboratory diagnosis and biosafety issues of biological warfare agents

CMI editorial report 2011 Clinical Microbiology and Infection

Z. Wang, Z. Cui, Y. Li, T. Hou, X. Liu, Y. Xi, Y. Liu, H. Li, Q. He

Structural studies of lipid A from a lipopolysaccharide of the Coxiella burnetii isolate RSA 514 (Crazy) P. Vadovic, A. Fuleova, R. Ihnatko, L. Skultety,

M. Or, M. Samish, T. Waner, S. Harrus

Elements of design: the knowledge on which we build

Frequencies of lipopolysaccharide-defined epitopes in Haemophilus influenzae type b and non-typable isolates determined with monoclonal antibodies Silvia.

Levofloxacin in the treatment of ventilator-associated pneumonia

G. Pappas Clinical Microbiology and Infection

Metagenomics and probiotics

Laboratory diagnosis of Clostridium difficile disease

A case of pleurisy associated with antibodies to Rickettsia conorii

S8 – S47 and O50 – O440 Clinical Microbiology and Infection

A. Bryskier Clinical Microbiology and Infection

The practice of travel medicine in Europe

Antibacterial drug discovery in the 21st century

Abstracts cont. Clinical Microbiology and Infection

Pandemic lineages of extraintestinal pathogenic Escherichia coli

Testing patients with non-specific symptoms for antibodies against Borrelia burgdorferi sensu lato does not provide useful clinical information about.

A.P. Underwood, J. Green Clinical Microbiology and Infection

Vaccines for the elderly

Immunohistochemical detection of Coxiella burnetii in an aortic graft

Statin use and clinical outcomes among pneumonia patients

Isolation of Coxiella burnetii from the blood of a patient with positive Anaplasma phagocytophilum serological results A.S. Santos, R. de Sousa, F. Alves,

Clinical Microbiology and Infection

Clinical Microbiology and Infection

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

The atypical pneumonias: clinical diagnosis and importance

Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe Robert D. Fox Clinical Microbiology.

Abstracts Clinical Microbiology and Infection

Virology: a scientific discipline facing new challenges

Modelling during an emergency: the 2009 H1N1 influenza pandemic

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

Three years experience of real-time PCR for the diagnosis of Q fever

Impact of antibiotic restrictions: the patient's perspective

Comparative study of pediculicidal effect of medical plants

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Presentation transcript:

A monoclonal antibody specific for a unique biomarker, virenose, in a lipopolysaccharide of Coxiella burnetii K. Palkovicova, R. Ihnatko, P. Vadovic, E. Betinova, L. Skultety, D. Frangoulidis, R. Toman Clinical Microbiology and Infection Volume 15, Pages 183-184 (December 2009) DOI: 10.1111/j.1469-0691.2008.02218.x Copyright © 2009 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Representative immunoblot of the LPSs of NM (1), Pr (2), S (3), 48 (4), 1/IIA (5), IXO (6) all in phase I, Cr (7) and S. typhosa (8), the whole cell lysates of NM (9) and Pr (11) in phase I, NM (10) and Pr (12) in phase II, and Cr (13) with the anti-Vir mAb. For abbreviations, see text. Clinical Microbiology and Infection 2009 15, 183-184DOI: (10.1111/j.1469-0691.2008.02218.x) Copyright © 2009 European Society of Clinical Infectious Diseases Terms and Conditions